The ABPI was reacting to the announcement by Roche, one of the world's top innovative pharmaceutical research-based companies, that it is investing more than £70 million on a new building to bring together 1,200 staff from its global pharmaceutical development and local sales and marketing teams.
"This is a big vote of confidence by Roche in Britain as a good place to operate," said Dr Trevor Jones, Director General of the ABPI. "It further proves that the UK can attract top pharmaceutical companies to invest in the country so long as it maintains a welcoming business environment.
"The UK still retains many attractions for the industry, but we must be very careful not to lose sight of the fact that there is major global competition from many other countries for the sort of investment and commitment that Roche is demonstrating."
Construction on the Roche site, in Welwyn Garden City, Hertfordshire, began this month and is scheduled to be completed late next year.
For further information, please contact: ABPI Press Office 020 7747 1410